InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by HUMPHREY RACHEL, Director. Director active across 1 company, notably Pyxis Oncology, Inc.. Cumulatively, 4 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €2k. Activity tracked since 24 March 2023. The latest transaction was disclosed on 14 April 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
1,400 shares@ US$0.972750.0% of flowCommon StockSEC:0000905148-26-001434
1,400 shares@ US$0.97270.0008% mcap50.0% of flowCommon StockSEC:0000905148-26-001434:0
38,741 shares0Common StockSEC:0000950170-24-038099:0
58,064 shares0Common StockSEC:0001209191-23-021408:0
4 of 4 declarations
About HUMPHREY RACHEL
Humphrey Rachel is a Director at Pyxis Oncology, Inc. She plays a key role in the governance of the company, contributing to strategic decisions and overseeing operations. Her experience in the biotechnology sector is valuable for the company's development.
